2008

28 August 2008: Announcement no. 2, 2008: Zealand Pharma today announced that Dr. David H...

Read More >
Product Pipeline

Zealand's Pipeline comprises 1 compound in phase III, 2 compounds in phase II, 3 compounds ...

Read More >

Business Development

Out-licensing

Zealand aims to establish partnerships with major pharmaceutical companies after having established “proof-of-concept”, or earlier if such partnership will advance the development of Zealand Pharma’s development candidates.

Contact person:
Mogens Vang Rasmussen
Chief Financial Officer and Responsible for Investor Relations and Communications
Phone: +45 4328 1204
e-mail: mvr@zp.dk

Tip a friend

Fill in the form below to tip a friend about this page.

When this page is updated you will be updated by e-mail.

2008

Product Pipeline

Business Development

Tip a friend

Subscribe